π Procter & Gamble Health FY25 Results: βΉ125 Dividend for a 9-Month Year β Who Needs 12 Months Anyway?
π At a Glance
P&G Health Ltd (NSE: PGHL) just pulled off a rare feat β a 27% PAT growth in just 9 months, all while changing their fiscal year! From JulyβMarch, the company posted βΉ918 crore in revenue and βΉ234 crore in PAT, backed by strong brand plays like Neurobion and Livogen. Oh, and the board’s feeling generous β total dividend? βΉ125/share.